» Articles » PMID: 33773529

The Impact of COVID-19 on Cancer Care in the Post Pandemic World: Five Major Lessons Learnt from Challenges and Countermeasures of Major Asian Cancer Centres

Abstract

Objective: The COVID-19 pandemic has dramatically affected healthcare services around Asia. The Asian National Cancer Centres Alliance and the Asia-Pacific Organisation for Cancer Prevention collaborated to assess the mid- and long- term impact of COVID-19 to cancer care in Asia.

Methods: The two entities organised a combined symposium and post-meeting interactions among representatives of major cancer centres from seventeen Asian countries to outlining major challenges and countermeasures.

Results: Participating stakeholders distilled five big questions. 1) "Will there be an explosion of late-stage cancers after the pandemic?" To address and recover from perceived delayed prevention, screening, treatment and care challenges, collaboration of key stakeholders in the region and alignment in cancer care management, policy intervention and cancer registry initiatives would be of essential value. 2) "Operations and Finance" The pandemic has resulted in significant material and financial casualties. Flagged acute challenges (shortages of supplies, imposition of lockdown) as well as longer-standing reduction of financial revenue, manpower, international collaboration, and training should also be addressed. 3) "Will telemedicine and technological innovations revolutionize cancer care?" Deploying and implementing telemedicine such as teleconsultation and virtual tumour boards were considered invaluable. These innovations could become a new regular practice, leading to expansion of tele-collaboration through collaboration of institutions in the region. 4) "Will virtual conferences continue after the pandemic?" Virtual conferences during the pandemic have opened new doors for knowledge sharing, especially for representatives of low- and middle-income countries in the region, while saving time and costs of travel. 5) "How do we prepare for the next pandemic or international emergency?" Roadmaps for action to improve access to appropriate patient care and research were identified and scrutinised.

Conclusion: Through addressing these five big questions, focused collaboration among members and with international organisations such as City Cancer Challenge will allow enhanced preparedness for future international emergencies.<br />.

Citing Articles

Experiences of patients and providers while using telemedicine in cancer care during COVID-19 pandemic: a systematic review and meta-synthesis of qualitative literature.

Mostafaei A, Sadeghi-Ghyassi F, Kabiri N, Hajebrahimi S Support Care Cancer. 2022; 30(12):10483-10494.

PMID: 36322247 PMC: 9628519. DOI: 10.1007/s00520-022-07415-6.


Impact of the COVID-19 and Socioeconomic Status on Access to Care for Otorhinolaryngology Patients.

Kim M, Park J, Cha H, Lee W, Hong S, Kim D Int J Environ Res Public Health. 2022; 19(19).

PMID: 36231170 PMC: 9565694. DOI: 10.3390/ijerph191911875.


Preparing for the Next Pandemic: An Asian National Cancer Centers Alliance (ANCCA) Initiative.

Gatellier L, Ong S, Matsuda T, Ramlee N, Lau F, Yusak S Asian Pac J Cancer Prev. 2021; 22(9):2945-2950.

PMID: 34582666 PMC: 8850880. DOI: 10.31557/APJCP.2021.22.9.2945.


Economic burden in treated Japanese patients with relapsed/refractory large B-cell lymphoma.

Tsutsue S, Makita S, Yi J, Crawford B Future Oncol. 2021; 17(33):4511-4525.

PMID: 34414783 PMC: 8386473. DOI: 10.2217/fon-2021-0400.


Decreased Global Interest in Oral Cancer During the COVID-19 Pandemic.

Dalanon J, Matsuka Y Asian Pac J Cancer Prev. 2021; 22(7):2117-2124.

PMID: 34319034 PMC: 8607088. DOI: 10.31557/APJCP.2021.22.7.2117.

References
1.
Pennell N, Dillmon M, Levit L, Moushey E, Alva A, Blau S . American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care. J Clin Oncol. 2020; 39(2):155-169. DOI: 10.1200/JCO.20.02953. View

2.
Antonoff M, Backhus L, Boffa D, Broderick S, Brown L, Carrott P . COVID-19 guidance for triage of operations for thoracic malignancies: A consensus statement from Thoracic Surgery Outcomes Research Network. J Thorac Cardiovasc Surg. 2020; 160(2):601-605. PMC: 7146695. DOI: 10.1016/j.jtcvs.2020.03.061. View

3.
Bakhtiar M, Elbuluk N, Lipoff J . The digital divide: How COVID-19's telemedicine expansion could exacerbate disparities. J Am Acad Dermatol. 2020; 83(5):e345-e346. PMC: 7365110. DOI: 10.1016/j.jaad.2020.07.043. View

4.
Jazieh A, Akbulut H, Curigliano G, Rogado A, Alsharm A, Razis E . Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative Study. JCO Glob Oncol. 2020; 6:1428-1438. PMC: 7529504. DOI: 10.1200/GO.20.00351. View

5.
Di Lorenzo G, Di Trolio R, Kozlakidis Z, Busto G, Ingenito C, Buonerba L . COVID 19 therapies and anti-cancer drugs: A systematic review of recent literature. Crit Rev Oncol Hematol. 2020; 152:102991. PMC: 7239789. DOI: 10.1016/j.critrevonc.2020.102991. View